EHF has been suggested to function as an oncosuppressor in prostate cancer and esophageal squamous cell carcinoma (ESCC) [11, 13, 14], and be frequently silenced by promoter methylation [13]. The gene discussed is EHF; the disease is esophageal squamous cell carcinoma.